Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 165 | 582 | 1,423 | 2,247 | 18,181 |
| Gross Profit | 165 | 582 | 1,423 | 2,247 | 18,181 |
| Operating Expenses | 29,828 | 31,613 | 41,998 | 52,441 | 56,478 |
| Operating Income | -29,663 | -31,031 | -40,575 | -50,194 | -38,297 |
| Other Income | 1,993 | 2,234 | 2,314 | 2,547 | 1,860 |
| Pre-tax Income | -27,670 | -28,797 | -38,261 | -47,647 | -36,437 |
| Net Income Continuous | -27,670 | -28,797 | -38,261 | -47,647 | -36,437 |
| Net Income | $-27,670 | $-28,797 | $-38,261 | $-47,647 | $-36,437 |
| EPS Basic Total Ops | -0.34 | -0.35 | -0.46 | -0.58 | -0.43 |
| EPS Basic Continuous Ops | -0.33 | -0.35 | -0.46 | -0.58 | -0.45 |
| EPS Diluted Total Ops | -0.34 | -0.35 | -0.46 | -0.58 | -0.43 |
| EPS Diluted Continuous Ops | -0.33 | -0.35 | -0.46 | -0.58 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.35 | -0.46 | -0.58 | -0.45 |
| EBITDA(a) | $-30,229 | $-31,880 | $-41,575 | $-51,110 | $-38,534 |